Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Merz Pharmaceuticals GmbH

https://www.merz.com/

Latest From Merz Pharmaceuticals GmbH

Biden Infrastructure Plan Offers Biopharma R&D Carrot, Tax Stick

Tens of billions would go to fund R&D, including Phase I and Phase II development of vaccines. But the plan would also crack down on inversions and offshoring.

Policy & Regulation Tax

New Trial Shows BENEFIT Of J&J/Auris’ Monarch Bronchoscopy Platform

New published results demonstrate J&J/Auris’ robotic is safe and effective at diagnosing peripheral pulmonary lesions.

Robotic Surgery Clinical Trials

Asia Deal Watch: Astellas Acquires Global Rights To KaliVir Oncolytic Virus Candidate

Plus deals involving SELLAS/3D Medicines, Kyowa Kirin/InveniAI, JW/Voronoi, Y-mAbs/Takeda, Horizon Discovery/Sanyou, Sentinel Oncology/PharmaEngine

Deals Business Strategies

Aducanumab Review: Looking For Precedents – Long Ago And Far Afield

The run-away US FDA advisory committee review of Biogen’s Alzheimer’s candidate was highly unusual. But like most things at the agency, not entirely unprecedented.

Advisory Committees Drug Approval Standards
See All

Company Information

  • Industry
  • Diversified
  • Other Names / Subsidiaries
    • BioteCon Therapeutics GmbH
    • Cabochon Aesthetics, Inc.
    • ON Light Sciences, Inc.
    • Ulthera, Inc.
    • Merz Pharmaceuticals GmbH
    • Merz Pharma France
    • Merz North America, Inc.
    • Merz Pharma (Schweiz) Ag
    • Merz Pharma GmbH
UsernamePublicRestriction

Register